ResearcherKagoshima UniversityActive in the last 2 years

Ryu Matsumoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8913-8377; OpenAlex author ID A5007613599. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2025: 2 papers

Papers 2

Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.omton.2025.201006 ↗
Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17183090 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chieri Nakayama · 1 shared paper, 2025 · strength 0.27
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090 ↗
Tetsuya Idichi · 1 shared paper, 2025 · strength 0.27
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090 ↗
Yuto Hozaka · 1 shared paper, 2025 · strength 0.27
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090 ↗
Yuko Mataki · 1 shared paper, 2025 · strength 0.27
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090 ↗
Takao Ohtsuka · 1 shared paper, 2025 · strength 0.27
- Paper Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Ad… DOI 10.3390/cancers17183090 ↗
Qizhi Cathy Yao · 1 shared paper, 2025 · strength 0.24
- Paper Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinom… DOI 10.1016/j.omton.2025.201006 ↗
Greyson W. G. Biegert · 1 shared paper, 2025 · strength 0.24
- Paper Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinom… DOI 10.1016/j.omton.2025.201006 ↗
Masataka Suzuki · 1 shared paper, 2025 · strength 0.24
- Paper Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinom… DOI 10.1016/j.omton.2025.201006 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.